These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 22048026)

  • 1. Micro RNA -214,-150,-146a and-125b target Huntingtin gene.
    Sinha M; Ghose J; Bhattarcharyya NP
    RNA Biol; 2011; 8(6):1005-21. PubMed ID: 22048026
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of miR-146a by RelA/NFkB and p53 in STHdh(Q111)/Hdh(Q111) cells, a cell model of Huntington's disease.
    Ghose J; Sinha M; Das E; Jana NR; Bhattacharyya NP
    PLoS One; 2011; 6(8):e23837. PubMed ID: 21887328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Full sequence of mutant huntingtin 3'-untranslated region and modulation of its gene regulatory activity by endogenous microRNA.
    Kim KH; Abu Elneel K; Shin JW; Keum JW; Seong D; Kwak S; Lee R; Gusella JF; MacDonald ME; Seong IS; Lee JM
    J Hum Genet; 2019 Oct; 64(10):995-1004. PubMed ID: 31296921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered microRNAs in STHdh(Q111)/Hdh(Q111) cells: miR-146a targets TBP.
    Sinha M; Ghose J; Das E; Bhattarcharyya NP
    Biochem Biophys Res Commun; 2010 Jun; 396(3):742-7. PubMed ID: 20451497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of huntingtin gene expression by miRNA-137, -214, -148a, and their respective isomiRs.
    Kozlowska E; Krzyzosiak WJ; Koscianska E
    Int J Mol Sci; 2013 Aug; 14(8):16999-7016. PubMed ID: 23965969
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of mitochondrial morphology and cell cycle by microRNA-214 targeting Mitofusin2.
    Bucha S; Mukhopadhyay D; Bhattacharyya NP
    Biochem Biophys Res Commun; 2015 Oct; 465(4):797-802. PubMed ID: 26307536
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA-22 (miR-22) overexpression is neuroprotective via general anti-apoptotic effects and may also target specific Huntington's disease-related mechanisms.
    Jovicic A; Zaldivar Jolissaint JF; Moser R; Silva Santos Mde F; Luthi-Carter R
    PLoS One; 2013; 8(1):e54222. PubMed ID: 23349832
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat Shock Factor 1-Regulated miRNAs Can Target Huntingtin and Suppress Aggregates of Mutant Huntingtin.
    Das S; Bhattacharyya NP
    Microrna; 2015; 4(3):185-93. PubMed ID: 26634350
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PRMT5- mediated symmetric arginine dimethylation is attenuated by mutant huntingtin and is impaired in Huntington's disease (HD).
    Ratovitski T; Arbez N; Stewart JC; Chighladze E; Ross CA
    Cell Cycle; 2015; 14(11):1716-29. PubMed ID: 25927346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-selective inhibition of huntingtin expression by switching to an miRNA-like RNAi mechanism.
    Hu J; Liu J; Corey DR
    Chem Biol; 2010 Nov; 17(11):1183-8. PubMed ID: 21095568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutant huntingtin promotes the fibrillogenesis of wild-type huntingtin: a potential mechanism for loss of huntingtin function in Huntington's disease.
    Busch A; Engemann S; Lurz R; Okazawa H; Lehrach H; Wanker EE
    J Biol Chem; 2003 Oct; 278(42):41452-61. PubMed ID: 12888569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inducing huntingtin inclusion formation in primary neuronal cell culture and in vivo by high-capacity adenoviral vectors expressing truncated and full-length huntingtin with polyglutamine expansion.
    Huang B; Schiefer J; Sass C; Kosinski CM; Kochanek S
    J Gene Med; 2008 Mar; 10(3):269-79. PubMed ID: 18067195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transcriptional dysregulation of coding and non-coding genes in cellular models of Huntington's disease.
    Bithell A; Johnson R; Buckley NJ
    Biochem Soc Trans; 2009 Dec; 37(Pt 6):1270-5. PubMed ID: 19909260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. microRNA-128a dysregulation in transgenic Huntington's disease monkeys.
    Kocerha J; Xu Y; Prucha MS; Zhao D; Chan AW
    Mol Brain; 2014 Jun; 7():46. PubMed ID: 24929669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of a dual-luciferase reporter system for in vivo visualization of MicroRNA biogenesis and posttranscriptional regulation.
    Lee JY; Kim S; Hwang DW; Jeong JM; Chung JK; Lee MC; Lee DS
    J Nucl Med; 2008 Feb; 49(2):285-94. PubMed ID: 18199619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-capacity adenoviral vector-mediated reduction of huntingtin aggregate load in vitro and in vivo.
    Huang B; Schiefer J; Sass C; Landwehrmeyer GB; Kosinski CM; Kochanek S
    Hum Gene Ther; 2007 Apr; 18(4):303-11. PubMed ID: 17472569
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Altered microRNA regulation in Huntington's disease models.
    Lee ST; Chu K; Im WS; Yoon HJ; Im JY; Park JE; Park KH; Jung KH; Lee SK; Kim M; Roh JK
    Exp Neurol; 2011 Jan; 227(1):172-9. PubMed ID: 21035445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of REST-regulated coding and non-coding RNAs in a cellular model of Huntington's disease.
    Soldati C; Bithell A; Johnston C; Wong KY; Stanton LW; Buckley NJ
    J Neurochem; 2013 Feb; 124(3):418-30. PubMed ID: 23145961
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Activation of the IkappaB kinase complex and nuclear factor-kappaB contributes to mutant huntingtin neurotoxicity.
    Khoshnan A; Ko J; Watkin EE; Paige LA; Reinhart PH; Patterson PH
    J Neurosci; 2004 Sep; 24(37):7999-8008. PubMed ID: 15371500
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Huntington's disease protein contributes to RNA-mediated gene silencing through association with Argonaute and P bodies.
    Savas JN; Makusky A; Ottosen S; Baillat D; Then F; Krainc D; Shiekhattar R; Markey SP; Tanese N
    Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10820-5. PubMed ID: 18669659
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.